Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Treatment Naive Patients With Diabetic Macular Edema
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 10 Oct 2017 Planned End Date changed from 1 Apr 2018 to 1 Dec 2018.
- 10 Oct 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Aug 2018.
- 02 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.